WP1066 is a novel JAK2 inhibitor and it suppresses proliferation and induces apoptosis in eythroid human cells carrying the JAK2 V617F mutation.
More Information Supplier PageWP1066 is a novel JAK2 inhibitor and it suppresses proliferation and induces apoptosis in eythroid human cells carrying the JAK2 V617F mutation.
More Information Supplier PageGSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor.
More Information Supplier PageGSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor.
More Information Supplier PageGSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor.
More Information Supplier Page
